Published in Am J Manag Care on June 01, 2012
Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes. J Gen Intern Med (2016) 0.91
Racial comparisons of diabetes care and intermediate outcomes in a patient-centered medical home. Diabetes Care (2013) 0.88
Factors Influencing the Increasing Disparity in LDL Cholesterol Control Between White and Black Patients With Diabetes in a Context of Active Quality Improvement. Am J Med Qual (2013) 0.77
Examining Factors Associated With Nonadherence And Identifying Providers Caring For Nonadherent Subgroups. J Pharm Health Serv Res (2017) 0.75
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol (1992) 60.45
State of disparities in cardiovascular health in the United States. Circulation (2005) 9.32
The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol (1997) 8.88
Patient adherence and medical treatment outcomes: a meta-analysis. Med Care (2002) 7.10
Trends in the quality of care and racial disparities in Medicare managed care. N Engl J Med (2005) 6.29
Research on the provider contribution to race/ethnicity disparities in medical care. Med Care (2002) 4.74
Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med (2008) 3.99
Estimating medication persistency using administrative claims data. Am J Manag Care (2005) 3.95
Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care (2004) 3.31
Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother (2008) 3.20
Geographic information systems: their use in environmental epidemiologic research. Environ Health Perspect (1997) 3.20
The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry (2003) 3.13
Racial injustice in health care. N Engl J Med (2000) 3.12
Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation (2006) 3.11
Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care (2005) 3.09
Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med (2007) 3.05
Racial disparities in diabetes care processes, outcomes, and treatment intensity. Med Care (2003) 2.88
Application of GEE procedures for sample size calculations in repeated measures experiments. Stat Med (1998) 2.84
The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care (2002) 2.83
Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care (2004) 2.83
The effect of chronic pain on diabetes patients' self-management. Diabetes Care (2005) 2.48
Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol (2004) 2.44
Linking automated databases for research in managed care settings. Ann Intern Med (1997) 2.25
Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care (2007) 2.22
Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research Into Action for Diabetes Study. Diabetes Care (2007) 1.95
Eliminating disparities in cardiovascular health: six strategic imperatives and a framework for action. Circulation (2005) 1.87
Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence. J Allergy Clin Immunol (2007) 1.67
Ethnic, gender, and age-related differences in treatment and control of dyslipidemia in hypertensive patients. Ethn Dis (2005) 1.65
Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol (2011) 1.56
Medication adherence and racial differences in A1C control. Diabetes Care (2008) 1.53
Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes. Diabetes Care (2008) 1.49
Understanding the gap between good processes of diabetes care and poor intermediate outcomes: Translating Research into Action for Diabetes (TRIAD). Med Care (2007) 1.48
Identifying risk factors for racial disparities in diabetes outcomes: the translating research into action for diabetes study. Med Care (2009) 1.39
Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res (2009) 1.33
Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care (2005) 1.32
Prescription drug co-payments and cost-related medication underuse. Health Econ Policy Law (2008) 1.31
Disparities in use of lipid-lowering medications among people with type 2 diabetes mellitus. Arch Intern Med (2003) 1.20
Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications. Prev Med (2004) 1.13
Adherence analysis using visual analog scale versus claims-based estimation. Ann Pharmacother (2007) 1.12
Racial differences in reaching target low-density lipoprotein goal among individuals treated with prescription statin therapy. Am Heart J (2006) 1.12
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: executive summary. Circulation (2005) 1.11
Patient race/ethnicity and patient-physician race/ethnicity concordance in the management of cardiovascular disease risk factors for patients with diabetes. Diabetes Care (2009) 1.02
Provider type and the receipt of general and diabetes-related preventive health services among patients with diabetes. Med Care (2001) 1.00
Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional study. BMC Cardiovasc Disord (2004) 0.98
How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes? Diabet Med (2008) 0.95
Sustained hyperglycemia among patients with diabetes: what matters when action is needed? Diabetes Care (2009) 0.87
Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II. J Gen Intern Med (2006) 0.85
Influence of patient race on physician prescribing decisions: a randomized on-line experiment. J Gen Intern Med (2009) 0.85
Racial differences in switching, augmentation, and titration of lipid-lowering agents by Medicare/Medicaid dual-eligible patients. Am J Manag Care (2007) 0.83
A program to reduce the disparity in the rate of biennial lipid profiles between African-American and white Medicare beneficiaries with diabetes mellitus in New York City. J Community Health (2006) 0.79
Disparities in the prevalence of medication therapy for hyperlipidemia in the elderly. Consult Pharm (2007) 0.76
Interpreting clinical trials of diabetic dyslipidaemia: new insights. Diabetes Obes Metab (2007) 0.76
Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care (2004) 3.31
Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol (2004) 2.44
When more is not better: treatment intensification among hypertensive patients with poor medication adherence. Circulation (2008) 2.37
Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis (2007) 2.03
Patient-physician colorectal cancer screening discussions and screening use. Am J Prev Med (2006) 1.87
FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf (2006) 1.83
Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence. J Allergy Clin Immunol (2007) 1.67
Monitoring of drugs with a narrow therapeutic range in ambulatory care. Am J Manag Care (2006) 1.60
Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol (2011) 1.56
Improving asthma care through recertification: a cluster randomized trial. Arch Intern Med (2007) 1.54
The impact of diabetes on employment and work productivity. Diabetes Care (2005) 1.50
Liver and thyroid monitoring in ambulatory patients prescribed amiodarone in 10 HMOs. J Manag Care Pharm (2006) 1.46
Frequency of serum creatinine monitoring during allopurinol therapy in ambulatory patients. Ann Pharmacother (2006) 1.42
Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab (2010) 1.36
Race-ethnicity, crime, and other factors associated with adherence to inhaled corticosteroids. J Allergy Clin Immunol (2006) 1.36
Reducing the health risks of diabetes: how self-determination theory may help improve medication adherence and quality of life. Diabetes Educ (2009) 1.36
Inconsistencies in patient perceptions and observer ratings of shared decision making: the case of colorectal cancer screening. Patient Educ Couns (2010) 1.35
The use of QALYs in clinical and patient decision-making: issues and prospects. Value Health (2009) 1.32
Colorectal carcinoma screening procedure use among primary care patients. Cancer (2005) 1.29
Factors contributing to the racial differences in prostate cancer mortality. BJU Int (2005) 1.26
Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med (2005) 1.23
Multicenter cluster-randomized trial of a multifactorial intervention to improve antihypertensive medication adherence and blood pressure control among patients at high cardiovascular risk (the COM99 study). Circulation (2010) 1.22
Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000-2001. J Am Geriatr Soc (2005) 1.22
Predicted quality-adjusted life years as a composite measure of the clinical value of diabetes risk factor control. Med Care (2007) 1.20
Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. J Nutr (2002) 1.19
Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis. Pharmacoepidemiol Drug Saf (2009) 1.18
A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. J Allergy Clin Immunol (2010) 1.16
Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. Mol Cancer Ther (2004) 1.16
Peak aerobic capacity predicts prognosis in patients with coronary heart disease. Am Heart J (2008) 1.15
Prioritization of evidence-based preventive health services during periodic health examinations. Am J Prev Med (2012) 1.14
Adherence analysis using visual analog scale versus claims-based estimation. Ann Pharmacother (2007) 1.12
The utility of administrative data for measuring adherence to cancer surveillance care guidelines. Med Care (2007) 1.12
Trends in diabetes incidence among 7 million insured adults, 2006-2011: the SUPREME-DM project. Am J Epidemiol (2014) 1.11
The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies. BMC Cardiovasc Disord (2014) 1.08
Race-ethnic differences in factors associated with inhaled steroid adherence among adults with asthma. Am J Respir Crit Care Med (2008) 1.07
Pharmacy and medical claims data identified migraine sufferers with high specificity but modest sensitivity. J Clin Epidemiol (2004) 1.05
Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy). Urology (2006) 1.05
Using claims-based measures to predict performance status score in patients with lung cancer. Cancer (2010) 1.05
Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro. Biochem Pharmacol (2004) 1.04
Use of guideline recommended follow-up care in cancer survivors: routine or diagnostic indications? Med Care (2006) 1.04
Relationship between recent short-acting beta-agonist use and subsequent asthma exacerbations. Ann Allergy Asthma Immunol (2008) 1.04
Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Saf (2007) 1.04
The economic impact of false-positive cancer screens. Cancer Epidemiol Biomarkers Prev (2004) 1.01
Survival among non-small cell lung cancer patients with poor performance status after first line chemotherapy. Lung Cancer (2012) 0.98
Aromatherapy as treatment for postoperative nausea: a randomized trial. Anesth Analg (2012) 0.97
E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters. Am J Clin Pathol (2006) 0.97
Patient-physician colorectal cancer screening discussions: delivery of the 5A's in practice. Am J Prev Med (2011) 0.97
The association between leptin and left ventricular hypertrophy: a population-based cross-sectional study. J Hypertens (2003) 0.96
Determining the value of disease management programs. Jt Comm J Qual Saf (2003) 0.95
Patient-rated importance and receipt of information for colorectal cancer screening. Cancer Epidemiol Biomarkers Prev (2011) 0.95
Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer. Urology (2009) 0.95
Protective effect of diabetes against metastasis in patients with non-small cell lung cancer. Arch Intern Med (2007) 0.94
Frequency of high-risk use of QT-prolonging medications. Pharmacoepidemiol Drug Saf (2006) 0.94
Colorectal cancer screening use among insured primary care patients. Am J Manag Care (2011) 0.93
Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancer. Lung Cancer (2011) 0.92
Are there race/ethnicity differences in outpatient congestive heart failure management, hospital use, and mortality among an insured population? Med Care (2004) 0.91
Improved survival with HPV among African Americans with oropharyngeal cancer. Clin Cancer Res (2013) 0.90
Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrollees. J Am Geriatr Soc (2005) 0.90
Acute pancreatitis in patients on chronic peritoneal dialysis: an increased risk? Am J Gastroenterol (2005) 0.89
A standardized relative resource cost model for medical care: application to cancer control programs. J Natl Cancer Inst Monogr (2013) 0.88
Timing and intensity of early fevers and the development of allergies and asthma. J Allergy Clin Immunol (2005) 0.88
Significance of p16 in Site-specific HPV Positive and HPV Negative Head and Neck Squamous Cell Carcinoma. Cancer Clin Oncol (2013) 0.87
A comparison of smokers' and nonsmokers' fruit and vegetable intake and relevant psychosocial factors. Behav Med (2009) 0.87
The challenge of conducting comparative effectiveness research in cancer: the impact of a fragmented U.S. health-care system. J Natl Cancer Inst Monogr (2013) 0.86
Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects. Biochem Pharmacol (2003) 0.86
Chemosensitization of hormone-refractory prostate cancer cells by curcumin to TRAIL-induced apoptosis. J Exp Ther Oncol (2005) 0.85
Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia? Ann Pharmacother (2007) 0.85
Race as a social construct in head and neck cancer outcomes. Otolaryngol Head Neck Surg (2011) 0.84
Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome. Clin Transplant (2012) 0.84
Differences in the reporting of care-related patient injuries to existing reporting systems. Jt Comm J Qual Saf (2003) 0.83
Effect of ezetimibe on major atherosclerotic disease events and all-cause mortality. Am J Cardiol (2012) 0.83
Iron overload in allogeneic hematopoietic stem cell transplant recipients. Arch Pathol Lab Med (2012) 0.82
Racial/Ethnic differences in health care visits made before suicide attempt across the United States. Med Care (2015) 0.82
Sexual health discussions with older adult patients during periodic health exams. J Sex Med (2014) 0.81
Epigenetic modulation of signal transduction pathways in HPV-associated HNSCC. Otolaryngol Head Neck Surg (2013) 0.81
SPARC affects glioma cell growth differently when grown on brain ECM proteins in vitro under standard versus reduced-serum stress conditions. Neuro Oncol (2003) 0.81
Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study. J Am Pharm Assoc (2003) (2014) 0.81
Vaccination with leukemia-loaded dendritic cells eradicates residual disease and prevent relapse. J Exp Ther Oncol (2006) 0.81
Factors associated with patient reports of positive physician relational communication. Patient Educ Couns (2012) 0.80
Risk factors for emergency department use among children with asthma using primary care in a managed care environment. Ambul Pediatr (2002) 0.80
Contraceptive insurance mandates and consistent contraceptive use among privately insured women. Med Care (2012) 0.80
Time to pharmacotherapy change in response to elevated HbA1c test results. Curr Med Res Opin (2006) 0.78